Oriflame Cosmetics - Publicering av rapport och...
Offentliggörande
Oriflame Cosmetics kommer att offentliggöra resultatet för helåret 2009 onsdagen
den 10 februari klockan 07.15.
Telefonkonferens
Bolaget kommer även att hålla en telefonkonferens onsdagen den 10 februari
klockan 09.30.
Telefonnummer:
Sverige: +46 (0)8 5853 6965
Storbritannien: +44 (0)20 7138 0827
USA: +1 718 354 1152
Luxemburg: +352 2088 0463
Schweiz: +41 (0)43 456 9228
Kod: 9825849/Oriflame
Det finns också möjlighet att lyssna direkt på telefonkonferensen via länk på
 www.oriflame.com <
http://www.oriflame.com/> eller www.financialhearings.com
<
http://www.financialhearings.com/>.
Värdar: Magnus Brännström, VD och koncernchef, och Gabriel Bennet,
finansdirektör.
För mer information, vänligen kontakta:
Patrik Linzenbold, Oriflame Investor Relations, +46 (0)765 422 709
Johan Wallinder, Financial Hearings, +46 (0)8 411 43 80
[HUG#1380267]
Release in PDF:
http://hugin.info/134730/R/1380267/339866.pdf
Pressmeddelande i PDF:
http://hugin.info/134730/R/1380267/339869.pdf
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.